During a career that has spanned almost 40 years Paul S. Anderson has received many awards. In 2006 he received the Priestley Medal, ACS’s highest honor. As a result of receiving this award he was part of the inaugural group of ACS Fellows selected in 2009. Some of the other awards he has received are the Philadelphia Section Award in 1992, Perkin Medal in 2002, and in 2003 the NAS Award for Chemistry in Service to the Society. In 1997 Paul served as ACS President.
Paul received a BS in chemistry from the University of Vermont in 1959. In 1963 he received his PhD in chemistry from the University of New Hampshire. In 1963-1964 he was a NIH Postdoctoral Fellow at Cornell. He then joined Merck and rose through the ranks and served as Vice President of Chemistry from 1988-1994. In 1994, he retired from Merck and moved to DuPont Pharmaceuticals serving as Sr. Vice President of Chemical and Physical Sciences from 1994-2001. Paul served as Vice President of Drug Discovery at Bristol-Myers Squibb from 2001-2002.
During his career Paul and his collaborators synthesized numerous compounds that became leading pharmaceutical products. He has published over 100 papers and has 19 patents. At Merck he was part of teams that led to the discovery of Crixivan and Sustiva. During retirement Paul has been asked to serve on the Scientific Advisory Board or the Board of Directors of many companies such as Albany Molecular Research, Vertex, Acadia, Centrose, and Kosan Biosciences, among others.
The article about Paul receiving the Priestley Medal can be found at http://pubs.acs.org/cen/news/83/i24/8324paulanderson.html and was published in C&EN on June 13, 2005